Praluent - Verkningsmekanism

The usual starting dose for PRALUENT is 75 mg administered subcutaneously once every 2 weeks. Patients requiring larger LDL-C reduction (>60%) may be started on 150 mg once every 2 weeks, or 300 mg once every 4 weeks (monthly), administered subcutaneously.²

Despite major advances in our understanding of atherosclerosis, ASCVD remains the leading cause of death globally.¹